Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pluristem Therapeutics Inc. Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies.
| Last: | $3.59 |
|---|---|
| Change Percent: | 1.7% |
| Open: | $3.59 |
| Close: | $3.53 |
| High: | $3.71 |
| Low: | $3.59 |
| Volume: | 7,789 |
| Last Trade Date Time: | 03/04/2026 12:09:57 pm |
| Market Cap: | $37,539,809 |
|---|---|
| Float: | 4,939,449 |
| Insiders Ownership: | 7.3% |
| Institutions: | 10 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.pluri-biotech.com |
| Country: | IL |
| City: | Haifa |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Pluri Inc. (NASDAQ: PLUR).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.